Steroid-related meningitis cases rise to 105

October 8, 2012 by Mike Stobbe

(AP)—Health officials say the number of people sickened by a deadly meningitis outbreak has now reached 105 cases.

The number of deaths rose by one to eight, with another in the U.S. state of Tennessee.

The updated the count on Monday. The list of nine states with reported cases stayed the same. Tennessee, Michigan, Virginia, Indiana, Florida, Maryland, Minnesota, North Carolina and Ohio previously reported cases.

Officials have tied the fungal meningitis outbreak to steroid shots for back pain. The steroid was made by a specialty pharmacy in Massachusetts.

The company has recalled the steroid which was sent to clinics in 23 states. The government last week urged doctors not to use any of the company's products.

Explore further: Rare US fungal meningitis outbreak grows; 5 dead (Update)


Related Stories

US clinics rush to warn of tainted steroid; 5 dead

October 5, 2012

(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five people have died.

Steroid-related meningitis cases rise to 47

October 5, 2012

(AP)—As the tally from a deadly meningitis outbreak rose Friday, health officials identified the medical clinics across the country that received steroid shots for back pain now linked to the illnesses.

US pharmacy linked to outbreak issues wide recall

October 7, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

CDC: More than 90 people ill with meningitis

October 7, 2012

(AP)—Health officials say they have now confirmed more than 90 cases of a rare fungal meningitis that has been linked to a steroid commonly used to ease back pain.

Recommended for you

Ebola virus mutations may help it evade drug treatment

September 11, 2015

Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.